TF and neoplasm: Further modification with targeting ligands, such as mannose (MAN) (Li et al., 2019) or transferrin (Tf) (Dos Santos Rodrigues et al., 2019), enables targeted recognition of specific receptors on tumor cells or the BBB (Eroğlu and İbrahim, 2020).